— Keysight Technologies (NYSE: KEYS) reported fourth-quarter 2019 earnings of $1.33 per share, vs. $1.18 per share expected.
— Net revenue grew 7% to $1.12 billion, vs. $1.09 billion expected.
— For Q1, expects revenue in the range of $1.045 billion to $1.065 billion. Adjusted earnings for this period expected between $1.04 and $1.10.
— KEYS shares fell 1% immediately following the announcement.
Most Popular
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) stock research summary | Q3 2021
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key
